Harrow stock plunges 20% on weaker-than-expected Q3 earnings

jurgenfr Shares of Harrow ( NASDAQ: HROW ) plunged 20% in post-market trading Wednesday after the eye care drugmaker’s Q3 earnings report missed Street estimates on the top and bottom lines. After market close, Harrow ( HROW ) reported Q3 revenue of $49.3 million, with a net.